Kissel, M., Berndt, S., Fiebig, L., Kling, S., Ji, Q., Gu, Q., . . . Zopf, D. (2017). Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma. Oncotarget.
シカゴスタイル引用形Kissel, Maria, et al. "Antitumor Effects of Regorafenib and Sorafenib in Preclinical Models of Hepatocellular Carcinoma." Oncotarget 2017.
MLA引用形式Kissel, Maria, et al. "Antitumor Effects of Regorafenib and Sorafenib in Preclinical Models of Hepatocellular Carcinoma." Oncotarget 2017.
警告: この引用は必ずしも正確ではありません.